CompaniesPercheron Therapeutics
Percheron Therapeutics logo

Percheron Therapeutics

active
Melbourne, Australia
Founded 2001
Website
About

Antisense drugs

Areas of Focus

Categories

Small Molecule PharmaceuticalAustralia
Clinical Trials (1)
View all

Total Trials

1

As Lead Sponsor

1

As Collaborator

0

Total Enrollment

48

By Phase

PHASE2: 1

By Status

TERMINATED: 1
Clinical Trials Pipeline1 trial
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2022
2023
2024
2025
2026
Today
NCT05938023
Hover over trial bars to see details

Recent Trials

NCT05938023Lead Sponsor
A Study of ATL1102 or Placebo in Participants With Non-ambulatory Duchenne Muscular Dystrophy
PHASE2Terminated
48 participants
Started: May 18, 2023 · Completed: Jan 15, 2025
Locations (1)
Headquarters
Melbourne, Australia
Map

Loading map...